Anti-sense and gene therapy approaches to the treatment of lymphomas

Bailliere's Clinical Haematology

Volumn 9, Issue 4, 1996, Pages 819-834

  Devereux, S ^a   Cotter, F E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRODRUG;

BONE MARROW TRANSPLANTATION; DRUG SENSITIVITY; GENE TARGETING; GENE THERAPY; IMMUNOMODULATION; IMMUNOTHERAPY; LYMPHOMA; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVIEW; STEM CELL; TUMOR SUPPRESSOR GENE;

EID: 0030513347     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(96)80055-2     Document Type: Article

References (87)

1. Adamson DJA Thompson WD Dawson AA P53 mutation and expression in lymphoma British Journal of Cancer 72 1995 150 154
2. Agrawal S Temsamani J Tang J Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice Proceedings of the National Academy of Sciences of the USA 88 1991 7595 7599
3. Aran L Gottesman M Pastan I Drug selected coexpression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector Proceedings of the National Academy of Sciences of the USA 91 1994 3176 3180
4. Bacon T Wickstrom E Walking along human c-myc mRNA with antisense oligodeoxynucleotides: maximum efficacy at the 5′ cap region Oncogene Research 6 1991 13 19
5. Baskar S Nabavi N Glimcher LH Ostrandrosenberg S Tumor-cells expressing major histocompatibility complex class-II and B7 activation molecules stimulate potent tumor-specific immunity Journal of Immunotherapy 14 1993 209 215
6. Bertolini F Demonte ML Corsini C Retrovirus-mediated transfer of the multidrug resistance gene into human haemopoietic progenitor cells British Journal of Haematology 88 1994 318 324
7. Bishop JM Molecular themes in oncogenesis Cell 64 1991 235 248
8. Bordignon C Bonini C Verzeletti S Transfer of the HSV-TK gene into donor peripheral-blood lymphocytes for in-vivo modulation of donor antitumor immunity after allogeneic bone-marrow transplantation Human Gene Therapy 6 1995 813 819
9. Bregni M Magni M Siena S Human peripheral blood haematopoietic progenitors are optimal targets of retroviral mediated gene transfer Blood 80 1992 1418 1422
10. Brenner MK Rill DR Holladay MS Gene marking to determine whether autologous marrow infusion restores long-term hematopoiesis in cancer-patients Lancet 342 1993 1134 1137
11. Brenner M Rill D Moen R Gene marking to trace origin of relapse after autologous bone marrow transplantation Lancet 341 1993 85 86
12. Chen LP Ashe S Brady WA Costimulation of antitumor immunity by the B7 counterreceptor for the lymphocyte-T molecules Cd28 and Ctla-4 Cell 71 1992 1093 1102
13. Cirielli C Riccioni T Yang CL Adenovirus-mediated gene-transfer of wild-type P53 results in melanoma cell apoptosis in-vitro and in-vivo International Journal of Cancer 63 1995 673 679
14. Cook DR Maxwell IH Glode LM Gene-therapy for B-cell lymphoma in a SCID mouse model using an immunoglobulin-regulated diphtheria-toxin gene delivered by a novel adenovirus-polylysine conjugate Cancer Biotherapy 9 1994 131 141
15. Cotter F Molecular pathology of lymphomas Cancer Surveys 16 1993 157 174
16. Cotter F Corbo M Raynaud F BCL-2 antisense therapy in lymphoma—in vitro and in vivo mechanisms, efficacy, pharmacokinetics and toxicity studies Annals of Oncology 7 supplement 3 1996 32
17. Cotter F Johnson P Hall P Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model Oncogene 9 1994 3049 3055
18. Culver KW Ram Z Wallbridge S In vivo gene-transfer with retroviral vector producer cells for treatment of experimental brain-tumors Science 256 1992 1550 1552
19. Daaka Y Wickstrom E Target dependence of antisense oligodeoxynucleotide inhibition of c-H-ras p21 expression and focus formation in T24-transformed NIH3T3 cells Oncogene Research 5 1990 267 275
20. Abstract. Dhondt V Caruso M Ward M Expression of the multidrug-resistance protein (Mrp) gene using retroviral vectors Blood 86 supplement 1995 1849
21. Dhondt V Caruso M Ward M Expression of the multidrug-resistance protein (Mrp) gene using retroviral vectors Blood 86 supplement 1995 1849
22. Dohner H Fischer K Bentz M P53 gene deletion predicts for poor survival and nonresponse to therapy with purine analogs in chronic B-cell leukemias Blood 85 1995 1580 1589
23. Dranoff G Jaffee E Lazenby A Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity Proceedings of the National Academy of Sciences of the USA 90 1993 3539 3543
24. Dumenco LL Warman B Hatzoglou M Increase in nitrosourea resistance in mammalian cells by retrovirally mediated gene transfer of bacterial O6-alkylguanine-DNA alkyltransferase Cancer Research 49 1989 6044 6051
25. Dunbar CE Cottler Fox M O'Shaughnessy JA Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation Blood 85 1995 3048 3057
26. Eder P Do Vine R Dagle J Walder J Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3′ exonuclease in plasma Antisense Research and Development 1 1991 141 151
27. Elshami AA Saavedra A Zhang H Gap-junctions play a role in the bystander effect of the herpes-simplex virus thymidine kinase ganciclovir system in-vitro Gene Therapy 3 1996 85 92
28. Gagandeep S Brew R Green B Prodrug-activated gene-therapy—involvement of an immunological component in the bystander effect Cancer Gene Therapy 3 1996 83 88
29. Galski H Sullivan M Willingham MC Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: resistance to daunomycin-induced leukopenia Molecular and Cellular Biology 9 1989 4357 4363
30. Germann UA Chin KV Pastan I Gottesman MM Retroviral transfer of a chimeric multidrug resistance-adenosine deaminase gene Faseb Journal 4 1990 1501 1507
31. Ghosh M Ghosh K Oligodeoxynucleotide analogs as informational drugs to regulate translation Nucleic Acids Symposia Series 24 1991 139 142
32. Gjerset RA Turla ST Sobol RE Use of wild-type P53 to achieve complete treatment sensitization of tumor-cells expressing endogenous mutant P53 Molecular Carcinogenesis 14 1995 275 285
33. Goodchild J Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides Proceedings of the National Academy of Sciences of the USA 85 1988 5507 5511
34. Harris MP Sutjipto S Wills KN Adenovirus-mediated P53 gene-transfer inhibits growth of human tumor-cells expressing mutant P53 protein Cancer Gene Therapy 3 1996 121 130
35. Hernandez L Fest T Cazorla M P53 gene-mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas Blood 87 1996 3351 3359
36. Heslop HE Ng CYC Li CF Long-term restoration of immunity against Epstein-Barrvirus infection by adoptive transfer of gene-modified virus-specific T-lymphocytes Nature Medicine 2 1996 551 555
37. Holt J Redner R Nienhuis A An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation Molecular and Cellular Biology 8 1988 967 973
38. Hsu FJ Benike C Fagnoni F Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells Nature Medicine 2 1996 52 58
39. Huber BE Richards CA Krenitsky TA Retroviral-mediated gene-therapy for the treatment of hepatocellular-carcinoma—an innovative approach for cancer-therapy Proceedings of the National Academy of Sciences of the USA 88 1991 8039 8043
40. Iversen P In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologue Anticancer Drug Design 6 1991 531 538
41. Kasahara N Dozy AM Kan YW Tissue-specific targeting of retroviral vectors through ligand-receptor interactions Science 266 1994 1373 1376
42. Kreig A Gmelig-Meyling F Gourley M Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible Antisense Research and Development 1 1991 161 171
43. Lo KM Lynch CA Gillies SD The use of a wild-type dihydrofolate reductase-encoding cDNA as a dominant selectable marker and induction of expression by methotrexate Gene 121 1992 365 369
44. Loke S Stein C Zhang X Characterization of oligonucleotide transport into living cells Proceedings of the National Academy of Sciences of the USA 86 1989 3474 3478
45. Mackensen A Herbst B Kohler G Delineation of the dendritic cell lineage by generating large numbers of Birbeck granule-positive Langerhans cells from human peripheral blood progenitor cells in vitro Blood 86 1995 2699 2707
46. Magni M Shammah S Schiro R Induction of cyclophosphamide-resistance by aldehydedehydrogenase gene-transfer Blood 87 1996 1097 1103
47. Maxwell IH Glode LM Maxwell F Expression of the diphtheria toxin-a-chain coding sequence under the control of promoters and enhancers from immunoglobulin genes as a means of directing toxicity to B-lymphoid cells Cancer Research 51 1991 4299 4304
48. McManaway M Neckers L Loke S Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide Lancet 335 1990 808 811
49. Mesnil M Piccoli C Tiraby G Bystander killing of cancer-cells by herpes-simplex virus thymidine kinase gene is mediated by connexins Proceedings of the National Academy of Sciences of the USA 93 1996 1831 1835
50. Milligan J Matteucci M Martin J Current concepts in antisense drug design Journal of Medicinal Chemistry 36 1993 1923 1937
51. Moolten FL Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes—paradigm for a prospective cancer control strategy Cancer Research 46 1986 5276 5281
52. Mullen CA Kilstrup M Blaese RM Transfer of the bacterial gene for cytosine deaminase to mammalian-cells confers lethal sensitivity to 5-fluorocytosine—a negative selection system Proceedings of the National Academy of Sciences of the USA 89 1992 33 37
53. Nishiyama T Kawamura Y Kawamoto K Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules Cancer Research 45 1985 1753 1761
54. Oldfield EH Ram Z Culver KW Gene-therapy for the treatment of brain-tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir Human Gene Therapy 4 1993 39 69
55. Papadopoulos EB Ladanyi M Emanuel D Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone-marrow transplantation New England Journal of Medicine 330 1994 1185 1191
56. Pardoll D New strategies for active immunotherapy with genetically engineered tumor-cells Current Opinion in Immunology 4 1992 619 623
57. Pocock C Al Mahdi N Hall P In vivo suppression of B-cell lymphoma with BCL-2 antisense oligonucleotides Blood 82 supplement 1 1993 200a
58. Podda S Ward M Himelstein A Transfer and expression of the human multiple drug resistance gene into live mice Proceedings of the National Academy of Sciences of the USA 89 1992 9676 9680
59. Puchalski RB Fahl WE Expression of recombinant glutathione S-transferase-Pi, Ya, or Yb-1 confers resistance to alkylating-agents Proceedings of the National Academy of Sciences of the USA 87 1990 2443 2447
60. Ram Z Culver KW Walbridge S Insitu retroviral-mediated gene-transfer for the treatment of brain-tumors in rats Cancer Research 53 1993 83 88
61. Reed J Cuddy M Haldar S BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense Proceedings of the National Academy of Sciences of the USA 87 1990 3660 3664
62. Reed J Stein C Subasinghe C Antisense mediated inhibition of BCL2 proto-oncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides Cancer Research 50 1990 6565 6570
63. Rill D Santana V Roberts W Direct demonstration that autologous bone marrow trans-plantation for solid tumours can return a multiplicity of tumorigenic cells Blood 84 1994 380 383
64. Roninson IB Chin JE Choi KG Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells Proceedings of the National Academy of Sciences of the USA 83 1986 4538 4542
65. Rooney CM Smith CA Ng CYC Use of gene-modified virus-specific T-lymphocytes to control Epstein Barr virus related lymphoproliferation Lancet 345 1995 9 13
66. Russell SJ Hawkins RE Winter G Retroviral vectors displaying functional antibody fragments Nucleic Acids Research 21 1993 1081 1085
67. Sallusto F Lanzavecchia A Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha Journal of Experimental Medicine 179 1994 1109 1118
68. Samejima Y Meruelo D Bystander killing induces apoptosis and is inhibited by forskolin Gene Therapy 2 1995 50 58
69. Servida P Rossini S Traversari C Gene-transfer into peripheral-blood lymphocytes for in-vivo immunomodulation of donor antitumor immunity in a patient affected by EBV-induced lymphoma Blood 82 1993 A214
70. Sorrentino B Brandt S Bodine D Selection of drug resistant bone marrow cells in-vivo after retroviral transfer of human MDR1 Science 257 1992 99
71. Stein C Cleary A Yakubov L Lederman S Phosphorothioate oligodeoxynucleotides bind to the third variable loop domain (v3) of HIV-1 gp120 Antisense Research and Development 3 1993 19 31
72. Stein C Cohen J Phosphorothioate oligodeoxynucleotide analogues J Cohen Oligodeoxynucleotides: antisense inhibitors of gene expression 1989 Macmillan London 97 117
73. Szczylik C Skorski T Nicolaides N Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides Science 253 1991 562 565
74. Takeuchi Y Porter C Strahan K Sensitization of cells and retroviruses to human serum by (α1–3) galactosyltransferase Nature 379 1996 85 99
75. Ueda K Cardarelli C Gottesman M Pastan I Expression of a full length cDNA for the human MDR-1 gene confers resistance to colchicine, doxorubicin and vinblastine Proceedings of the National Academy of Sciences of the USA 84 1987 3004 3008
76. Ueda K Clark D Chen C-J The human multidrug resistance (mdr-1) gene Journal of Biological Chemistry 262 1987 505 508
77. van Zeijl M Johann S Closs E A human amphotropic retrovirus receptor is a second member of the gibbon ape leukaemia virus receptor family Proceedings of the National Academy of Sciences of the USA 91 1994 1168 1172
78. Vile RG Hart IR Use of tissue-specific expression of the herpes-simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA Cancer Research 53 1993 3860 3864
79. Ward M Richardson C Pioli P Transfer and expression of the human multiple drug resistance gene in human CD34+ cells Blood 84 1994 1408 1414
80. Webb A Cunningham D Cotter F Phase I BCL-2 antisense trial: Preliminary results Annals of Oncology 7 supplement 3 1996 32
81. Wellstein A Zugmaier G Califanp J Tumor growth dependent of Kaposi's sarcoma derived fibroblast growth factor inhibited by pentosan polysulphate Journal of the National Cancer Institute 83 1991 716 720
82. Wickstrom EL Bacon T Gonzalez A Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxy-nucleotide targeted against c-myc mRNA Proceedings of the National Academy of Sciences of the USA 85 1988 1028 1032
83. Wintersberger U Ribonucleases H of retroviral and cellular origin Pharmacology and Therapeutics 48 1990 259 280
84. Yakubov L Deeva E Zarytova V Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proceedings of the National Academy of Sciences of the USA 86 1989 6454 6458
85. Yamamoto S Yamamoto T Kataoka T Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity Journal of Immunology 148 1992 4072 4076
86. Zamecnik P Stephensen M Inhibition of Rous sarcoma virus replication and cell trans-formation by a specific oligodeoxynucleotide Proceedings of the National Academy of Sciences of the USA 75 1978 280 284
87. Zugmaier G Lippman M Wellstein A Inhibition by pentosan polysulphate (PPS) of heparinbinding growth factors released from tumor cells and blockage by PPS of tumor growth in animals Journal of the National Cancer Institute 84 1993 1716 1724